76 related articles for article (PubMed ID: 17174926)
1. The ins and outs of MHC class II proteins in dendritic cells.
Santambrogio L; Strominger JL
Immunity; 2006 Dec; 25(6):857-9. PubMed ID: 17174926
[TBL] [Abstract][Full Text] [Related]
2. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination.
Shin JS; Ebersold M; Pypaert M; Delamarre L; Hartley A; Mellman I
Nature; 2006 Nov; 444(7115):115-8. PubMed ID: 17051151
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C delta stimulates antigen presentation by Class II MHC in murine dendritic cells.
Majewski M; Bose TO; Sillé FC; Pollington AM; Fiebiger E; Boes M
Int Immunol; 2007 Jun; 19(6):719-32. PubMed ID: 17446207
[TBL] [Abstract][Full Text] [Related]
4. Endosomal sorting of MHC class II determines antigen presentation by dendritic cells.
van Niel G; Wubbolts R; Stoorvogel W
Curr Opin Cell Biol; 2008 Aug; 20(4):437-44. PubMed ID: 18582577
[TBL] [Abstract][Full Text] [Related]
5. Old lysosomes, new tricks: MHC II dynamics in DCs.
Chow AY; Mellman I
Trends Immunol; 2005 Feb; 26(2):72-8. PubMed ID: 15668121
[No Abstract] [Full Text] [Related]
6. Division of labor by dendritic cells.
Iwasaki A
Cell; 2007 Feb; 128(3):435-6. PubMed ID: 17289563
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells from spondylarthritis-prone HLA-B27-transgenic rats display altered cytoskeletal dynamics, class II major histocompatibility complex expression, and viability.
Dhaenens M; Fert I; Glatigny S; Haerinck S; Poulain C; Donnadieu E; Hacquard-Bouder C; André C; Elewaut D; Deforce D; Breban M
Arthritis Rheum; 2009 Sep; 60(9):2622-32. PubMed ID: 19714626
[TBL] [Abstract][Full Text] [Related]
8. MHC Class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II.
Herrmann TL; Agrawal RS; Connolly SF; McCaffrey RL; Schlomann J; Kusner DJ
J Leukoc Biol; 2007 Sep; 82(3):686-99. PubMed ID: 17586661
[TBL] [Abstract][Full Text] [Related]
9. Self-reporting peptides illuminate the MHC groove.
Yewdell JW; Lev A
Nat Chem Biol; 2007 Apr; 3(4):201-2. PubMed ID: 17372601
[No Abstract] [Full Text] [Related]
10. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
Choi YE; Yu HN; Yoon CH; Bae YS
Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634
[TBL] [Abstract][Full Text] [Related]
11. Fate of MHC class II molecules in human dendritic cells.
Hanau D; Saudrais C; Haegel-Kronenberger H; Bohbot A; De La Salle H; Salamero J
Eur J Dermatol; 1999; 9(1):7-12. PubMed ID: 9920978
[No Abstract] [Full Text] [Related]
12. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
[TBL] [Abstract][Full Text] [Related]
13. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain.
Faure-André G; Vargas P; Yuseff MI; Heuzé M; Diaz J; Lankar D; Steri V; Manry J; Hugues S; Vascotto F; Boulanger J; Raposo G; Bono MR; Rosemblatt M; Piel M; Lennon-Duménil AM
Science; 2008 Dec; 322(5908):1705-10. PubMed ID: 19074353
[TBL] [Abstract][Full Text] [Related]
14. Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon.
Jaehn PS; Zaenker KS; Schmitz J; Dzionek A
Eur J Immunol; 2008 Jul; 38(7):1822-32. PubMed ID: 18581320
[TBL] [Abstract][Full Text] [Related]
15. The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.
Terme M; Mignot G; Ullrich E; Bonmort M; Minard-Colin V; Jacquet A; Schultze JL; Kroemer G; Leclerc C; Chaput N; Zitvogel L
Cancer Res; 2009 Aug; 69(16):6590-7. PubMed ID: 19679551
[TBL] [Abstract][Full Text] [Related]
16. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells.
Napoletano C; Rughetti A; Agervig Tarp MP; Coleman J; Bennett EP; Picco G; Sale P; Denda-Nagai K; Irimura T; Mandel U; Clausen H; Frati L; Taylor-Papadimitriou J; Burchell J; Nuti M
Cancer Res; 2007 Sep; 67(17):8358-67. PubMed ID: 17804752
[TBL] [Abstract][Full Text] [Related]
18. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.
Kuwano Y; Prazma CM; Yazawa N; Watanabe R; Ishiura N; Kumanogoh A; Okochi H; Tamaki K; Fujimoto M; Tedder TF
Int Immunol; 2007 Aug; 19(8):977-92. PubMed ID: 17804692
[TBL] [Abstract][Full Text] [Related]
19. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
20. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
